BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Protocadherin-7 contributes to maintenance of bone homeostasis through regulation of osteoclast multinucleation

  • Kim, Hyunsoo (Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine) ;
  • Takegahara, Noriko (Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine) ;
  • Walsh, Matthew C. (Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine) ;
  • Ueda, Jun (Research Institute for Microbial Diseases, Osaka University) ;
  • Fujihara, Yoshitaka (Research Institute for Microbial Diseases, Osaka University) ;
  • Ikawa, Masahito (Research Institute for Microbial Diseases, Osaka University) ;
  • Choi, Yongwon (Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine)
  • Received : 2020.03.06
  • Accepted : 2020.04.06
  • Published : 2020.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Osteoclasts are hematopoietic-derived cells that resorb bone. They are required to maintain proper bone homeostasis and skeletal strength. Although osteoclast differentiation depends on receptor activator of NF-κB ligand (RANKL) stimulation, additional molecules further contribute to osteoclast maturation. Here, we demonstrate that protocadherin-7 (Pcdh7) regulates formation of multinucleated osteoclasts and contributes to maintenance of bone homeostasis. We found that Pcdh7 expression is induced by RANKL stimulation, and that RNAi-mediated knockdown of Pcdh7 resulted in impaired formation of osteoclasts. We generated Pcdh7-deficient mice and found increased bone mass due to decreased bone resorption but without any defect in bone formation. Using an in vitro culture system, it was revealed that formation of multinucleated osteoclasts is impaired in Pcdh7-deficient cultures, while no apparent defects were observed in differentiation and function of Pcdh7-deficient osteoblasts. Taken together, these results reveal an osteoclast cell-intrinsic role for Pcdh7 in maintaining bone homeostasis.

Keywords

References

  1. Teitelbaum SL and Ross FP (2003) Genetic regulation of osteoclast development and function. Nat Rev Genet 4, 638-649 https://doi.org/10.1038/nrg1122
  2. Moutsopoulos NM, Konkel J, Sarmadi M et al (2014) Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17-driven inflammatory bone loss. Sci Transl Med 6, 229ra40 https://doi.org/10.1126/scitranslmed.3007696
  3. Souza PP and Lerner UH (2013) The role of cytokines in inflammatory bone loss. Immunol Invest 42, 555-622 https://doi.org/10.3109/08820139.2013.822766
  4. Takayanagi H (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7, 292-304 https://doi.org/10.1038/nri2062
  5. Walsh MC, Kim N, Kadono Y et al (2006) Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol 24, 33-63 https://doi.org/10.1146/annurev.immunol.24.021605.090646
  6. Boyle JW, Simonet SW and Lacey LD (2003) Osteoclast differentiation and activation. Nature 423, 337-342 https://doi.org/10.1038/nature01658
  7. Aguilar PS, Baylies MK, Fleissner A et al (2013) Genetic basis of cell-cell fusion mechanisms. Trends Genet 29, 427-437 https://doi.org/10.1016/j.tig.2013.01.011
  8. Kim H, Walsh MC, Takegahara N et al (2017) The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts. Sci Rep 7, 196 https://doi.org/10.1038/s41598-017-00139-2
  9. Takeichi M (2014) Dynamic contacts: rearranging adherens junctions to drive epithelial remodelling. Nat Rev Mol Cell Biol 15, 397-410 https://doi.org/10.1038/nrm3802
  10. Leckband DE and de Rooij J (2014) Cadherin adhesion and mechanotransduction. Annu Rev Cell Dev Biol 30, 291-315 https://doi.org/10.1146/annurev-cellbio-100913-013212
  11. Hayashi S and Takeichi M (2015) Emerging roles of protocadherins: from self-avoidance to enhancement of motility. J Cell Sci 128, 1455-1464 https://doi.org/10.1242/jcs.166306
  12. Kim SY, Yasuda S, Tanaka H, Yamagata K and Kim H (2011) Non-clustered protocadherin. Cell Adh Migr 5, 97-105 https://doi.org/10.4161/cam.5.2.14374
  13. Peek SL, Mah KM and Weiner JA (2017) Regulation of neural circuit formation by protocadherins. Cell Mol Life Sci 74, 4133-4157 https://doi.org/10.1007/s00018-017-2572-3
  14. Nakamura H, Nakashima T, Hayashi M et al (2014) Global epigenomic analysis indicates protocadherin-7 activates osteoclastogenesis by promoting cell-cell fusion. Biochem Biophys Res Commun 455, 305-311 https://doi.org/10.1016/j.bbrc.2014.11.009
  15. Helming L and Gordon S (2009) Molecular mediators of macrophage fusion. Trends Cell Biol 19, 514-522 https://doi.org/10.1016/j.tcb.2009.07.005
  16. Oren-Suissa M and Podbilewicz B (2007) Cell fusion during development. Trends Cell Biol 17, 537-546 https://doi.org/10.1016/j.tcb.2007.09.004
  17. Kim H, Takegahara N, Walsh MC et al (2020) IgSF11 regulates osteoclast differentiation through association with the scaffold protein PSD-95. Bone Res 8, 5 https://doi.org/10.1038/s41413-019-0080-9
  18. Kahr I, Vandepoele K and van Roy F (2013) Delta-protocadherins in health and disease. Prog Mol Biol Transl Sci 116, 169-192 https://doi.org/10.1016/B978-0-12-394311-8.00008-X
  19. Heggem M and Bradley R (2003) The cytoplasmic domain of Xenopus NF-protocadherin interacts with TAF1/set. Dev Cell 4, 419-429 https://doi.org/10.1016/S1534-5807(03)00036-4
  20. Bradley R, Espeseth A and Kintner C (1998) NF-protocadherin, a novel member of the cadherin superfamily, is required for Xenopus ectodermal differentiation. Curr Biol 8, 325-334 https://doi.org/10.1016/S0960-9822(98)70132-0
  21. Zhou X, Updegraff BL, Guo Y et al (2017) PROTOCA DHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis. Cancer Res 77, 187-197 https://doi.org/10.1158/0008-5472.CAN-16-1267-T
  22. Wang L, Guo X, Zhou W et al (2018) Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption. Acta Biomater 73, 488-499 https://doi.org/10.1016/j.actbio.2018.04.013
  23. Vanhalst K, Kools P, Staes K, van Roy F and Redies C (2005) delta-Protocadherins: a gene family expressed differentially in the mouse brain. Cell Mol Life Sci 62, 1247-1259 https://doi.org/10.1007/s00018-005-5021-7
  24. Zaidi M (2007) Skeletal remodeling in health and disease. Nat Med 13, 791-801 https://doi.org/10.1038/nm1593
  25. Matsuo K and Irie N (2008) Osteoclast-osteoblast communication. Arch Biochem Biophys 473, 201-209 https://doi.org/10.1016/j.abb.2008.03.027
  26. Miyazaki T, Tokimura F and Tanaka S (2014) A review of denosumab for the treatment of osteoporosis. Patient Prefer Adherence 8, 463-471 https://doi.org/10.2147/PPA.S46192
  27. Baron R, Ferrari S and Russell RG (2011) Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 48, 677-692 https://doi.org/10.1016/j.bone.2010.11.020